1.700
+0,00%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +82.7% | +3312.6% | 2 / 3 | +9.4% | +3.69 pp | +47.52 pp | +6.3% | 0.18 | 7.97 | 5,8 | +9,4% | −0,5 | +82,7% | 7.97 | 7.52 | +5,9% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.700 (close price on 2026-10-19)EPS (TTM): 213,4
Financial charts
1.Revenue & growth
VND bn5,76Q2/26
1.Revenue & growth
VND bn5,76Q2/26
2.Profit & growth
VND bn-0,76Q2/26
3.Profit mix (Penman)
VND bn5,34Q2/26
4.Margins & cost structure
%8.4%Q2/26
5.Returns & cash cycle
% · days-38.1%Q2/26
6.Earnings quality & cash
VND bn-98,2Q2/26
7.Asset structure
VND bn153Q2/26
8.Funding & debt health
VND bn · times153Q2/26
9.Revenue backlog
VND bn13,7Q2/26
10.Valuation
times · %8,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-29Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-28.3%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26